Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial

Overview of attention for article published in Diabetologia, August 2009

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (96th percentile)
High Attention Score compared to outputs of the same age and source (91st percentile)

Mentioned by

news: 3 news outlets
policy: 1 policy source

patent: 48 patents

Citations

dimensions_citation: 710 Dimensions

Readers on

mendeley: 350 Mendeley
citeulike: 1 CiteULike

Summary News Policy documents Patents Dimensions citations

So far, Altmetric has seen 3 news stories from 3 outlets.

Impact of Liraglutide to Semaglutide Conversion on Glycemic Control and Cost Savings at a Veterans Affairs Medical Center

Pediatric News , 03 Oct 2023

1. ElSayed NA, Aleppo G, Aroda VR, et al. 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.

CHAPTER 5. Clinical Guideline for Pharmacological Management of Adults With Type 2 Diabetes

AJMC, 22 Jun 2018

Om P. Ganda, MD, Chair, Clinical Oversight Committee; Alissa Segal, PharmD, CDE, CDTC; Elizabeth Blair, MS, ANP-BC, CDE, CDTC…

GLP-1 Receptor Agonists in Type 2 Diabetes -- NICE Guidelines Versus Clinical Practice

Medscape, 15 Sep 2015

European Medicines Agency. Byetta: EPAR - Summary for the public. 2009. http://www.ema.europa.eu/docs/en_GB/document_library/EPAR…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity.